No effect of vitamin D administration plus dietary intervention on emerging cardiovascular risk factors in patients with metabolic syndrome
Background: Patients with metabolic syndrome (MetS) have low serum 25-hydroxyvitamin D (25(OH)VitD) levels. Low 25(OH)VitD has been associated with several emerging cardiovascular disease (CVD) risk factors, while VitD administration may ameliorate them. Aim: To study the effect of 25(OH)VitD supple...
Main Authors: | Stefania E. Makariou, Moses Elisaf, Anna Challa, Constantinos C. Tellis, Alexandros D. Tselepis, Evangelos N. Liberopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Journal of Nutrition & Intermediary Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352385918300719 |
Similar Items
-
Dapagliflozin in patients with type 2 diabetes mellitus
by: Theodosios D. Filippatos, et al.
Published: (2015-02-01) -
Effects of Serum Estradiol on Proprotein Convertase Subtilisin/Kexin Type 9 Levels and Lipid Profiles in Women Undergoing In Vitro Fertilization
by: Anna Papanikolaou, et al.
Published: (2024-01-01) -
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
by: Petros Spyridonas Adamidis, et al.
Published: (2024-02-01) -
PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation
by: Ioannis Dafnis, et al.
Published: (2022-10-01) -
LDL cholesterol estimation in patients with the metabolic syndrome
by: Tselepis Alexandros D, et al.
Published: (2006-04-01)